TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) — Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical machine firm centered on the event and commercialization of progressive surgical applied sciences for single entry robotic-assisted surgical procedure (RAS), right this moment introduced the disclosing of its subsequent era know-how and participation in conferences to help the strategic assessment course of introduced on November 30, 2022 alongside the 41st Annual J.P. Morgan Healthcare Convention being held January 9-12 in San Francisco, CA. A video highlighting the corporate’s newest innovation in robotic-assisted surgical procedure is obtainable on the corporate’s web site www.titanmedicalinc.com.
Cary G. Vance, Titan’s President and CEO, commented, “We’re trying ahead to assembly with strategic consumers and traders in the course of the convention week and offering a future view into what a three-arm single entry robotic-assisted surgical procedure know-how might appear to be. With the time it takes to convey complicated merchandise to market within the regulated medical machine business, you will need to constantly envision the following era. Our deal with purpose-driven innovation has at all times been on the forefront of our work. We’re excited to share our three-arm design that was independently created by Titan and builds upon applied sciences developed for our two-arm system and people generated underneath a beforehand executed and accomplished growth and license settlement, and addresses evolving buyer wants in single-access robotic surgical procedure.”
If you need to schedule a gathering in the course of the convention, please electronic mail Kristen Galfetti at [email protected].
About Titan Medical
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical machine firm headquartered in Toronto, Ontario with operations in Chapel Hill, North Carolina, is concentrated on enhancing robotic assisted surgical procedure (RAS) utilizing progressive know-how by means of a single entry level. The Enos™ robotic single entry surgical system is being developed with an ergonomic focus to offer a surgical expertise that imitates real-life actions that surgeons demand and contains multi-articulating devices designed to permit surgeons an elevated vary of movement in a confined area, with dexterity and the flexibility to exert the forces crucial to finish widespread surgical duties. With the Enos system, Titan intends to initially pursue gynecologic surgical indications. On November 30, 2022, the corporate introduced the graduation of a strategic assessment course of that may contemplate a full vary of strategic options together with company sale, merger or different enterprise mixture, a sale of all or a portion of the corporate’s property, strategic funding or different important transaction.
Enos™ is a trademark of Titan Medical Inc.
For extra info, go to www.titanmedicalinc.com and comply with @TitanMedical on Twitter and LinkedIn.
This information launch comprises “forward-looking statements” inside the which means of relevant Canadian and U.S. securities legal guidelines, which replicate the present expectations of administration of the corporate’s future development, outcomes of operations, efficiency and enterprise prospects and alternatives. Ahead-looking statements are ceaselessly, however not at all times, recognized by phrases resembling “could”, “would”, “might”, “will”, “anticipate”, “imagine”, “plan”, “count on”, “intend”, “estimate”, “potential for” and related expressions, though these phrases might not be current in all forward-looking statements. Ahead-looking statements that seem on this launch could embrace, with out limitation, references to: the corporate’s strategic assessment course of and the potential consequence thereof; the corporate’s participation in conferences to help the strategic assessment course of; the corporate’s three-arm single entry RAS know-how; the corporate’s deal with single entry robotic assisted surgical procedure; the Enos system offering a surgical expertise that imitates real-life actions; the Enos platform being designed to advertise sooner restoration, shorter hospital stays, decrease danger of an infection, fewer scars and fewer post-operative ache; Titan’s mission of bettering outcomes for sufferers, hospitals and surgeons; and the corporate’s intention to initially pursue gynecologic surgical indications with the Enos system.
These forward-looking statements replicate administration’s present beliefs with respect to future occasions and are based mostly on info at the moment obtainable to administration that, whereas thought-about cheap by administration as of the date on which the statements are made, are inherently topic to important enterprise, financial and aggressive uncertainties and contingencies which might lead to actions, occasions, situations, outcomes, efficiency or achievements to be materially completely different from these projected within the forward-looking statements. Ahead-looking statements contain important dangers, uncertainties and assumptions and lots of elements might trigger the corporate’s precise outcomes, efficiency or achievements to be materially completely different from any future outcomes, efficiency or achievements which may be expressed or implied by such forward-looking statements. Such elements and assumptions embrace, however usually are not restricted to, the Firm’s skill to retain key personnel; its skill to execute on its enterprise plans and methods; the sufficiency of its working capital to proceed to fund its operations throughout its strategic assessment course of and different elements listed within the “Threat Elements” part of the corporate’s Annual Report for the fiscal yr ended December 31, 2021 (which can be seen at www.sedar.com and at www.sec.gov). Ought to a number of of those dangers or uncertainties materialize, or ought to assumptions underlying the forward-looking statements show incorrect, precise outcomes, efficiency, or achievements could fluctuate materially from these expressed or implied by the forward-looking statements contained on this information launch. These elements ought to be thought-about fastidiously, and potential traders shouldn’t place undue reliance on the forward-looking statements.
Though the forward-looking statements contained within the information launch are based mostly upon what administration at the moment believes to be cheap assumptions and the corporate has tried to determine vital elements that would trigger precise actions, occasions, situations, outcomes, efficiency or achievements to vary materially from these described in forward-looking statements, the corporate can’t guarantee potential traders that precise outcomes, efficiency or achievements might be in step with these forward-looking statements. Besides as required by regulation, the corporate expressly disclaims any intention or obligation to replace or revise any forward-looking statements whether or not because of new info, future occasions or in any other case. Accordingly, traders shouldn’t place undue reliance on forward-looking statements. All of the forward-looking statements are expressly certified by the foregoing cautionary statements.
Vice President, Investor Relations
& Company Communications